Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2022 Filed Oct 7, 2022 21:57 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 33.5905 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053151 · doc4.xml · derivative · entry 13 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,484.7042 Underlying: Common Shares · 33.5905 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:57 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 192.4884 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053151 · doc4.xml · derivative · entry 12 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,968.8885 Underlying: Common Shares · 192.4884 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:57 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 214.1018 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053151 · doc4.xml · derivative · entry 11 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,211.0769 Underlying: Common Shares · 214.1018 shares Expires 2025-02-21 F10 · derivative.exercise_price: The shares reported represents an award of performance based restricted share units (the "2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:57 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 26.2917 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053151 · doc4.xml · derivative · entry 10 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,727.5202 Underlying: Common Shares · 26.2917 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F9 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:57 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 330.7759 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053151 · doc4.xml · derivative · entry 8 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,314.934 Underlying: Common Shares · 330.7759 shares Expires 2024-02-22 F7 · derivative.exercise_price: The shares reported represent an award of performance base restricted share units (the "2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:57 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 33.254 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053151 · doc4.xml · derivative · entry 7 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,449.7947 Underlying: Common Shares · 33.254 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F6 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:57 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 24.441 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053151 · doc4.xml · derivative · entry 5 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,535.5266 Underlying: Common Shares · 24.441 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 18:02 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 587.9291 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053171 · doc4.xml · derivative · entry 17 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,992.203 Underlying: Common Shares · 587.9291 shares Expires 2025-02-25 F16 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 18:02 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 188.481 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053171 · doc4.xml · derivative · entry 16 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,553.16 Underlying: Common Shares · 188.481 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F15 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F15 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 18:02 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 343.9126 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053171 · doc4.xml · derivative · entry 15 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,677.7475 Underlying: Common Shares · 343.9126 shares Expires 2024-02-19 F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 18:02 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 82.3953 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053171 · doc4.xml · derivative · entry 14 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,547.7493 Underlying: Common Shares · 82.3953 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 18:02 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 112.9265 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053171 · doc4.xml · derivative · entry 13 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,715.0813 Underlying: Common Shares · 112.9265 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 18:02 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 207.1187 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053171 · doc4.xml · derivative · entry 12 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,486.6451 Underlying: Common Shares · 207.1187 shares Expires 2025-02-21 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2020-2 PBRSUs") granted to the Reporting Person. The 2020-2 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 18:02 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 267.6272 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053171 · doc4.xml · derivative · entry 11 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,763.8461 Underlying: Common Shares · 267.6272 shares Expires 2025-02-21 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2020-1 PBRSUs") granted to the Reporting Person. The 2020-1 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 18:02 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 64.5731 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053171 · doc4.xml · derivative · entry 10 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,698.8608 Underlying: Common Shares · 64.5731 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F9 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 18:02 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 551.2931 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053171 · doc4.xml · derivative · entry 8 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,191.5567 Underlying: Common Shares · 551.2931 shares Expires 2024-02-22 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 18:02 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 93.3119 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053171 · doc4.xml · derivative · entry 7 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,680.2429 Underlying: Common Shares · 93.3119 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F6 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 18:02 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 88.8774 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053171 · doc4.xml · derivative · entry 6 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,220.2041 Underlying: Common Shares · 88.8774 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:59 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 391.9495 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053154 · doc4.xml · derivative · entry 7 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,661.1285 Underlying: Common Shares · 391.9495 shares Expires 2025-02-25 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:59 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 90.7567 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053154 · doc4.xml · derivative · entry 6 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,415.1709 Underlying: Common Shares · 90.7567 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F8 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:59 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 150.2222 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053154 · doc4.xml · derivative · entry 5 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,584.1662 Underlying: Common Shares · 150.2222 shares Expires 2024-12-15 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021-2 PBRSUs") granted to the Reporting Person. The 2021-2 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on December 15, 2024, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:59 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 150.2222 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053154 · doc4.xml · derivative · entry 4 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,584.1662 Underlying: Common Shares · 150.2222 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2022, December 15, 2023 and December 15, 2024. F6 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2022, December 15, 2023 and December 15, 2024. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:59 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 151.5074 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053154 · doc4.xml · derivative · entry 3 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,717.4932 Underlying: Common Shares · 151.5074 shares Expires 2024-09-01 F4 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021-1 PBRSUs") granted to the Reporting Person. The 2021-1 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on September 1, 2024, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:59 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 114.5657 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053154 · doc4.xml · derivative · entry 2 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,885.1339 Underlying: Common Shares · 114.5657 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F3 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F3 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 22:03 UTC |
Cil Jose E.Chief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,469.8425 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053173 · doc4.xml · derivative · entry 26 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,482.548 Underlying: Common Shares · 1,469.8425 shares Expires 2025-02-25 F30 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F21 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 22:03 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 450.6473 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053173 · doc4.xml · derivative · entry 25 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,750.4831 Underlying: Common Shares · 450.6473 shares Expires not disclosed F17 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F18 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F29 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F29 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 22:03 UTC |
Cil Jose E.Chief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,031.7378 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053173 · doc4.xml · derivative · entry 24 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,033.2424 Underlying: Common Shares · 1,031.7378 shares Expires 2024-02-19 F28 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F21 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 22:03 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 214.5399 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053173 · doc4.xml · derivative · entry 23 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,256.5244 Underlying: Common Shares · 214.5399 shares Expires not disclosed F17 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F18 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F27 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F27 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 22:03 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 338.7796 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053173 · doc4.xml · derivative · entry 22 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,145.2438 Underlying: Common Shares · 338.7796 shares Expires not disclosed F17 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F18 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F26 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F26 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 22:03 UTC |
Cil Jose E.Chief Executive Officer
|
GrantPerformance Share Units · Derivative | 2,676.2722 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053173 · doc4.xml · derivative · entry 21 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,638.4614 Underlying: Common Shares · 2,676.2722 shares Expires 2025-02-21 F25 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F21 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 22:03 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 183.9134 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053173 · doc4.xml · derivative · entry 20 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,079.3151 Underlying: Common Shares · 183.9134 shares Expires not disclosed F17 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F18 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F24 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F24 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 22:03 UTC |
Cil Jose E.Chief Executive Officer
|
GrantPerformance Share Units · Derivative | 3,032.1122 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053173 · doc4.xml · derivative · entry 19 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,553.5616 Underlying: Common Shares · 3,032.1122 shares Expires 2024-02-22 F23 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. F21 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 22:03 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 158.3645 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053173 · doc4.xml · derivative · entry 18 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,428.8466 Underlying: Common Shares · 158.3645 shares Expires not disclosed F17 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F18 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F22 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F22 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 22:03 UTC |
Cil Jose E.Chief Executive Officer
|
GrantPerformance Share Units · Derivative | 2,528.0858 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053173 · doc4.xml · derivative · entry 17 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,265.4912 Underlying: Common Shares · 2,528.0858 shares Expires 2023-02-23 F20 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2018 PBRSUs") granted to the Reporting Person. The 2018 PBRSUs had a three-year performance period beginning January 1, 2015 and ending December 31, 2018 and will vest 100% on February 23, 2023, which is the fifth anniversary of the grant date. F21 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 22:03 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 180.8497 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053173 · doc4.xml · derivative · entry 16 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,761.4805 Underlying: Common Shares · 180.8497 shares Expires not disclosed F17 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F18 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F19 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F19 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:56 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 342.9619 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053150 · doc4.xml · derivative · entry 19 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,579.1252 Underlying: Common Shares · 342.9619 shares Expires 2025-02-25 F15 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:56 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 169.6329 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053150 · doc4.xml · derivative · entry 18 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,597.844 Underlying: Common Shares · 169.6329 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F14 · derivative.exercise_date: The restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F14 · derivative.expiration_date: The restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:56 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 206.3476 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053150 · doc4.xml · derivative · entry 17 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,406.6485 Underlying: Common Shares · 206.3476 shares Expires 2024-02-19 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:56 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 80.7733 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053150 · doc4.xml · derivative · entry 16 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,379.4781 Underlying: Common Shares · 80.7733 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:56 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 67.7559 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053150 · doc4.xml · derivative · entry 15 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,029.0488 Underlying: Common Shares · 67.7559 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:56 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 267.6272 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053150 · doc4.xml · derivative · entry 14 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,763.8461 Underlying: Common Shares · 267.6272 shares Expires 2025-02-21 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:56 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 79.9777 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053150 · doc4.xml · derivative · entry 13 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,296.9478 Underlying: Common Shares · 79.9777 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F9 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:56 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 551.2931 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053150 · doc4.xml · derivative · entry 11 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,191.5567 Underlying: Common Shares · 551.2931 shares Expires 2024-02-22 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:56 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 94.2932 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053150 · doc4.xml · derivative · entry 10 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,782.0439 Underlying: Common Shares · 94.2932 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F6 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:56 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 110.9175 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053150 · doc4.xml · derivative · entry 9 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,506.6636 Underlying: Common Shares · 110.9175 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:57 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 146.9823 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053152 · doc4.xml · derivative · entry 13 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,248.0507 Underlying: Common Shares · 146.9823 shares Expires 2025-02-25 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2022 and to the extent earned will vest 100% on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:57 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 71.8094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053152 · doc4.xml · derivative · entry 12 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,449.5583 Underlying: Common Shares · 71.8094 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 2025. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 2025. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:57 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 35.808 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053152 · doc4.xml · derivative · entry 11 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,714.7458 Underlying: Common Shares · 35.808 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:57 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 115.493 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053152 · doc4.xml · derivative · entry 10 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,981.3331 Underlying: Common Shares · 115.493 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 21:57 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 107.0509 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053152 · doc4.xml · derivative · entry 9 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,105.5385 Underlying: Common Shares · 107.0509 shares Expires 2025-02-21 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.